Nirvana Raises $24.2M to Streamline Health Insurance Eligibility Verification

Nirvana Raises $24.2M to Streamline Health Insurance Eligibility Verification

New York-based healthcare technology company Nirvana has secured $24.2 million in a Series A funding round to streamline healthcare insurance verification with Artificial Intelligence (AI) and Machine Learning (ML). Co-founded in 2020 by Akshay Venkitasubramanian, Kelvin Chan, and Urvish Parikh, Nirvana’s platform leverages AI and ML to help healthcare providers improve their transparency regarding health insurance eligibility and verification.

Please login to comment on this Post

Most Visited Posts

1

Satellite imaging Market to be Worth $6.8 Billion by 2030

Meticulous Research®—a leading global...

2

اعلن الكم عن وصيتي جاي احس واصل سراي

اصدقائي اقربائي، اعلن الكم...

3

Does the UI/UX design course have good placements?

UI UX design school help you to find a job in...

4

كلمات اغنية كفى احمد فتحي

كلمات اغنية كفى احمد فتحي...

5

Medad ERP

يوفر موقع مداد افضل برامج...

6

Medical Imaging Perth

At Perth Medical Imaging Ellenbrook, we focus on traditional values in providing our radiology service with care and a commitment to excellence in a comfortable environment.

7

Secure Your Site with Comodo Secure Socket Layer with Free Seal

Protect your website with Comodo SSL Certificates and a free trust seal. Build visitor confidence and secure data instantly. Gain a free trust seal, enhance credibility, and protect users. Activate strong security now.

8

A Guide for Startups

Starting a new business is an exciting journey,...

9

Receive $50 Payments Over & Over

Tired of costly programs that don't deliver? So were we. That's why we built the first-ever payout model where you keep 100% of the profits. Real results, real earnings—finally!  

10

Sell Your Cartier Jewellery And Get Instant Cash

If you are wondering to sell your cartier jewellery anywhere  in London, Luxbrokers is on stop shop for you. We buy all cartier jewellery specially love bracelet. Contact us.

Follow Us on